These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19626585)

  • 1. Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas.
    Chen HY; Shao CJ; Chen FR; Kwan AL; Chen ZP
    Int J Cancer; 2010 Apr; 126(8):1944-1954. PubMed ID: 19626585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between methylation status of ERCC1 promoter and radiosensitivity in glioma cell lines.
    Liu ZG; Chen HY; Cheng JJ; Chen ZP; Li XN; Xia YF
    Cell Biol Int; 2009 Oct; 33(10):1111-7. PubMed ID: 19664717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-à-vis chemotherapy drug cytotoxicity in human glioma.
    Chen H; Shao C; Shi H; Mu Y; Sai K; Chen Z
    J Neurooncol; 2007 May; 82(3):257-62. PubMed ID: 17151930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MZF1 possesses a repressively regulatory function in ERCC1 expression.
    Yan QW; Reed E; Zhong XS; Thornton K; Guo Y; Yu JJ
    Biochem Pharmacol; 2006 Mar; 71(6):761-71. PubMed ID: 16426580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
    Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
    Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of O6-methylguanine-DNA methyltransferase promoter methylation in chemotherapy for glioma].
    Zheng CQ; Ji SP; Gong F; Li AM; Tai JL; Zhang YP
    Ai Zheng; 2009 Jun; 28(6):575-80. PubMed ID: 19635193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The methylation and mRNA expression of SLC5A8 and TMS1/ASC genes in human glioma].
    Jiang Z; Li XG; Hu J; Lu DR; Zhou W; Jiang YQ; Li CY
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):292-7. PubMed ID: 17456354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
    Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
    Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines.
    Li W; Jie Z; Li Z; Liu Y; Gan Q; Mao Y; Wang X
    Mol Med Rep; 2014 Jun; 9(6):2423-8. PubMed ID: 24699918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERCC1 expression and chemosensitivity in uterine cervical adenocarcinoma cells.
    Torii Y; Kato R; Minami Y; Hasegawa K; Fujii T; Udagawa Y
    Anticancer Res; 2014 Jan; 34(1):107-15. PubMed ID: 24403450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
    Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B
    J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy.
    Wang H; Zhang SY; Wang S; Lu J; Wu W; Weng L; Chen D; Zhang Y; Lu Z; Yang J; Chen Y; Zhang X; Chen X; Xi C; Lu D; Zhao S
    Neuro Oncol; 2009 Dec; 11(6):790-802. PubMed ID: 19289490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes.
    Tanaka S; Kamitani H; Amin MR; Watanabe T; Oka H; Fujii K; Nagashima T; Hori T
    J Neurooncol; 2000; 46(2):157-71. PubMed ID: 10894369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.
    Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG
    Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.
    Möllemann M; Wolter M; Felsberg J; Collins VP; Reifenberger G
    Int J Cancer; 2005 Jan; 113(3):379-85. PubMed ID: 15455350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.
    Li W; Melton DW
    Oncogene; 2012 May; 31(19):2412-22. PubMed ID: 21996734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer.
    Hsu DS; Lan HY; Huang CH; Tai SK; Chang SY; Tsai TL; Chang CC; Tzeng CH; Wu KJ; Kao JY; Yang MH
    Clin Cancer Res; 2010 Sep; 16(18):4561-71. PubMed ID: 20823140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of xeroderma pigmentosum complementation group C protein predicts cisplatin resistance in lung adenocarcinoma patients.
    Lai TC; Chow KC; Fang HY; Cho HC; Chen CY; Lin TY; Chiang IP; Ho SP
    Oncol Rep; 2011 May; 25(5):1243-51. PubMed ID: 21327329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients.
    Shalaby SM; El-Shal AS; Abdelaziz LA; Abd-Elbary E; Khairy MM
    Gene; 2018 Feb; 644():66-73. PubMed ID: 29080834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.